価格表

在庫・価格 : 2025年04月26日 08時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-alpha Synuclein, Rabbit
データシート
GTX112799 GNTジーンテックス
GeneTex International Corporation
25 μl ¥30,000
(未発注)
追加

在庫・価格 : 2025年04月26日 08時45分 現在

Anti-alpha Synuclein, Rabbit

  • 商品コード:GTX112799
  • メーカー:GNT
  • 包装:25μl
  • 価格: ¥30,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Bast鱈as-Candia S et al. Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease. Environ. Toxicol. ;30(6):656-63
Bast鱈as-Candia S et al
PubMed
2 Lee S et al. MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation. Korean J. Physiol. Pharmacol. 2017 Nov;21(6):625-632
Lee S et al
2017/01/01
Application: Western Blot (WB), Reactivity: Mouse PubMed
3 Zeng H et al. Transcriptomic analysis of α-synuclein knockdown after T3 spinal cord injury in rats. BMC Genomics 2019 Nov;20(1):851
Zeng H et al
2019/01/01
PubMed
4 Han C et al. Exosomes from patients with Parkinson's disease are pathological in mice. J. Mol. Med. 2019 09;97(9):1329-1344
Han C et al
2019/01/01
PubMed
5 Akiyama T et al. Synthetic mRNA-based differentiation method enables early detection of Parkinson's phenotypes in neurons derived from Gaucher disease-induced pluripotent stem cells. Stem Cells Transl Med 2021 Apr;10(4):572-581
Akiyama T et al
2021/01/01
PubMed
6 Kwon Y et al. Amitriptyline interferes with autophagy-mediated clearance of protein aggregates via inhibiting autophagosome maturation in neuronal cells. Cell Death Dis 2020 10;11(10):874
Kwon Y et al
2020/01/01
PubMed
7 Yin S et al. Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease? Mol Neurobiol 2022 Feb;59(2):1333-1344
Yin S et al
2022/01/01
PubMed
8 Chen HY et al. Clinical and functional characterization of a novel STUB1 frameshift mutation in autosomal dominant spinocerebellar ataxia type 48 (SCA48). J Biomed Sci 2021 Sep;28(1):65
Chen HY et al
2021/01/01
PubMed
9 Park SJ et al. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease. PLoS Pathog 2021 10;17(10):e1010018
Park SJ et al
2021/01/01
PubMed
10 Kim W et al. An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models. Nat Commun 2023 Jul;14(1):4283
Kim W et al
2023/01/01
PubMed
  • No.: 1
  • 文献情報:
    Bast鱈as-Candia S et al. Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease. Environ. Toxicol. ;30(6):656-63
    Bast鱈as-Candia S et al
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Lee S et al. MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation. Korean J. Physiol. Pharmacol. 2017 Nov;21(6):625-632
    Lee S et al
    2017/01/01
  • 備考:
    Application: Western Blot (WB), Reactivity: Mouse
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Zeng H et al. Transcriptomic analysis of α-synuclein knockdown after T3 spinal cord injury in rats. BMC Genomics 2019 Nov;20(1):851
    Zeng H et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Han C et al. Exosomes from patients with Parkinson's disease are pathological in mice. J. Mol. Med. 2019 09;97(9):1329-1344
    Han C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Akiyama T et al. Synthetic mRNA-based differentiation method enables early detection of Parkinson's phenotypes in neurons derived from Gaucher disease-induced pluripotent stem cells. Stem Cells Transl Med 2021 Apr;10(4):572-581
    Akiyama T et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kwon Y et al. Amitriptyline interferes with autophagy-mediated clearance of protein aggregates via inhibiting autophagosome maturation in neuronal cells. Cell Death Dis 2020 10;11(10):874
    Kwon Y et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Yin S et al. Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease? Mol Neurobiol 2022 Feb;59(2):1333-1344
    Yin S et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chen HY et al. Clinical and functional characterization of a novel STUB1 frameshift mutation in autosomal dominant spinocerebellar ataxia type 48 (SCA48). J Biomed Sci 2021 Sep;28(1):65
    Chen HY et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Park SJ et al. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease. PLoS Pathog 2021 10;17(10):e1010018
    Park SJ et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kim W et al. An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models. Nat Commun 2023 Jul;14(1):4283
    Kim W et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed